Leverkusen, Germany

Hans-Peter Stupp


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Hans-Peter Stupp: Pioneering Advancements in Pharmaceutical Chemistry

Introduction

Hans-Peter Stupp is a prominent inventor based in Leverkusen, Germany, with a notable contribution to pharmaceutical chemistry. With a total of two patents to his name, Stupp has focused his research and innovation on novel chemical compounds that hold great potential for medicinal applications. His work is characterized by meticulous research and development aimed at advancing the field of therapeutics.

Latest Patents

Hans-Peter Stupp's latest patents include the innovative and complex compounds centered around the following titles: "Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives." This patent presents the invention of novel optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acids and their derivatives. These compounds are of great interest due to their therapeutic applications and their potential benefits in medicinal chemistry.

Career Highlights

Stupp's career is prominently linked with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sectors. His work at Bayer has enabled him to pursue cutting-edge research and collaborate in the development of innovative compounds that may lead to significant breakthroughs in drug development.

Collaborations

Throughout his career, Hans-Peter Stupp has collaborated with esteemed colleagues in the field, including Stefan Bartel and Thomas Jaetsch. These collaborations have facilitated a productive exchange of ideas and have spurred further innovations, reinforcing Bayer's commitment to advancing healthcare and pharmaceutical solutions.

Conclusion

Hans-Peter Stupp stands as a significant figure in the realm of pharmaceutical innovation. His contributions, especially in the development of novel compounds, reflect the continuous effort to push the boundaries of medicinal chemistry. With his patents paving the way for potential therapeutic advancements, Stupp's work at Bayer Aktiengesellschaft embodies the spirit of innovation essential for future breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…